ABIN2846106

antibody from antibodies-online

Targeting: NDUFAF4 bA22L21.1, C6orf66, HRPAP20, HSPC125, My013

Western blot (Recommended by provider)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

ABIN2846106

Provider

antibodies-online

Product name

anti-NADH Dehydrogenase (Ubiquinone) 1 alpha Subcomplex, Assembly Factor 4 (NDUFAF4) (AA 33-61), (N-Term) antibody

Antibody type

Polyclonal

Description

This antibody is purified through a protein A column, followed by peptide affinity purification.

Reactivity

Human

Host

Rabbit

Epitope

AA 33-61, N-Term

Antibody clone number

RB32512

Vial size

80 μL

Storage

NDUFAF4 Antibody (N-term) can be refrigerated at 2-8°C for up to 6 months. For long term storage, place the at -20°C.

References

Submitted references

Lack of complex I is associated with oncocytic thyroid tumours.

Zimmermann FA, Mayr JA, Neureiter D, Feichtinger R, Alinger B, Jones ND, Eder W, Sperl W, Kofler B
British journal of cancer 2009 May 5;100(9):1434-7

---

Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease.

Saada A, Vogel RO, Hoefs SJ, van den Brand MA, Wessels HJ, Willems PH, Venselaar H, Shaag A, Barghuti F, Reish O, Shohat M, Huynen MA, Smeitink JA, van den Heuvel LP, Nijtmans LG
American journal of human genetics 2009 Jun;84(6):718-27

---

C6ORF66 is an assembly factor of mitochondrial complex I.

Saada A, Edvardson S, Rapoport M, Shaag A, Amry K, Miller C, Lorberboum-Galski H, Elpeleg O
American journal of human genetics 2008 Jan;82(1):32-8

---

Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen.

Tozlu-Kara S, Roux V, Andrieu C, Vendrell J, Vacher S, Lazar V, Spyratos F, Tubiana-Hulin M, Cohen P, Dessen P, Lidereau R, Bièche I
Journal of molecular endocrinology 2007 Oct;39(4):305-18

---

HRPAP20: a novel calmodulin-binding protein that increases breast cancer cell invasion.

Karp CM, Shukla MN, Buckley DJ, Buckley AR
Oncogene 2007 Mar 15;26(12):1780-8

Immunohistochemistry

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

IHC